Plain-English translation of NCT06541652 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that gathers information from patients in France who have been diagnosed with rare types of liver cancer. Researchers want to collect medical records, imaging results, and tumor tissue samples to better understand how these cancers develop and which treatments work best. By studying real-world patient experiences, the team hopes to identify the most effective treatment sequences for future patients.
Rare liver cancers are not well understood because they occur in very few people, making it hard for doctors to know which treatments work best. This study exists to fill that gap by collecting detailed information about these cancers and learning from patients who have already received treatment in everyday medical practice.
You likely qualify if…
You likely don't qualify if…
As a participant, you would allow researchers to review your medical records, imaging scans, and pathology reports from your diagnosis and treatment. If you are willing, you would also consent to researchers using your stored tumor tissue sample and blood samples for biological studies. The study is retrospective, meaning it looks back at information already collected — there are no new visits or treatments required.
AI-generated summary from trial data · Jul 14, 2026 · Not medical advice
France